)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
Galderma Group (GALD) investor relations material
Galderma Group H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary24 Jul, 2025
Executive summary
Achieved record H1 2025 net sales of $2.45B, up 12.2% year-over-year at constant currency, with growth across all product categories and geographies.
Core EBITDA reached $555M, up 9.5% year-over-year, with a margin of 22.7%, slightly ahead of expectations and supported by strong Nemluvio ramp-up.
Major product launches, including Nemluvio and Ralfidesse/Relfydess, exceeded expectations and drove market share gains.
Net leverage reduced to 2.1x, with $110M debt repaid, $323M in share repurchases, and $1.04B term loan refinanced.
Full-year net sales growth guidance raised to 12–14% at constant currency, with Core EBITDA margin guidance confirmed at ~23%.
Financial highlights
Net sales grew 12.2% year-over-year in H1 2025, with Q2 growth accelerating to 15.8%.
Core EBITDA of $555M, margin at 22.7%; underlying profitability (excluding nimolizumab impact) at 28.9%.
Core net income reached $329M, with basic and diluted EPS rising to $0.82 from $0.20 year-over-year.
Gross profit margin stable at 74.6% of net sales; gross margin impacted by US pricing pressures but partially offset by favorable mix.
Cash flow from operating activities surged to $551M, supported by strong operations and lower CapEx.
Outlook and guidance
Full-year net sales growth guidance raised to 12–14% at constant currency (previously 10–12%).
Core EBITDA margin guidance maintained at approximately 23%.
Neuromodulators expected to see 11–13% net sales growth for the year; fillers and biostimulators to accelerate in H2.
Dermatological skincare to sustain growth, with acceleration in Q4; therapeutic dermatology to benefit from Nemluvio ramp-up.
No material impact anticipated from new tax legislation or hyperinflation in key markets.
How did share repurchases impact treasury shares?
Explain the restructuring provisions drivers.
What is driving the neuromodulators sales growth?
Assess Relfydess's impact on Dysport sales.
Detail Nemluvio's potential new indications.
Explain the rationale for share repurchases.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Galderma Group earnings date
Q3 2025 TU23 Oct, 2025
Next Galderma Group earnings date
Q3 2025 TU23 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
Galderma Group AG, based in Zug, Switzerland, is a global dermatology company. It is committed exclusively to the field of dermatological care, encompassing a wide range of products and treatments across three main areas: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. Galderma's offerings include widely recognized brands and solutions aimed at enhancing skin health for consumers and patients, supported by robust research and development efforts. The company is headquartered in Zug, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage